Swain SM - Search Results

1

Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial.

Bear HD, Tang G, Rastogi P, Geyer CE Jr, Liu Q, Robidoux A, Baez-Diaz L, Brufsky AM, Mehta RS, Fehrenbacher L, Young JA, Senecal FM, Gaur R, Margolese RG, Adams PT, Gross HM, Costantino JP, Paik S, Swain SM, Mamounas EP, Wolmark N. Bear HD, et al. Among authors: swain sm. Lancet Oncol. 2015 Sep;16(9):1037-1048. doi: 10.1016/S1470-2045(15)00041-8. Epub 2015 Aug 10. Lancet Oncol. 2015. PMID: 26272770 Free PMC article. Clinical Trial.

2

Selection of therapy for stage III breast cancer.

Swain SM. Swain SM. Surg Clin North Am. 1990 Oct;70(5):1061-80. doi: 10.1016/s0039-6109(16)45230-8. Surg Clin North Am. 1990. PMID: 2218819 Free article. Review.

3

Mitoxantrone, 5-FU, and leucovorin in breast cancer.

Swain SM, Honig SF. Swain SM, et al. Med Pediatr Oncol. 1994;22(6):370-4. doi: 10.1002/mpo.2950220603. Med Pediatr Oncol. 1994. PMID: 8152397

4

The role of primary chemotherapy in early breast cancer.

Harris L, Swain SM. Harris L, et al. Among authors: swain sm. Semin Oncol. 1996 Feb;23(1 Suppl 2):31-42. Semin Oncol. 1996. PMID: 8614843 Review.

5

Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.

Swain SM, Whaley FS, Gerber MC, Weisberg S, York M, Spicer D, Jones SE, Wadler S, Desai A, Vogel C, Speyer J, Mittelman A, Reddy S, Pendergrass K, Velez-Garcia E, Ewer MS, Bianchine JR, Gams RA. Swain SM, et al. J Clin Oncol. 1997 Apr;15(4):1318-32. doi: 10.1200/JCO.1997.15.4.1318. J Clin Oncol. 1997. PMID: 9193323 Clinical Trial.

6

Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy.

Swain SM, Whaley FS, Gerber MC, Ewer MS, Bianchine JR, Gams RA. Swain SM, et al. J Clin Oncol. 1997 Apr;15(4):1333-40. doi: 10.1200/JCO.1997.15.4.1333. J Clin Oncol. 1997. PMID: 9193324 Clinical Trial.

7

Breast cancer at the millennium: the new frontier.

Mamounas E, Swain S. Mamounas E, et al. Semin Oncol. 2001 Jun;28(3):219-20. doi: 10.1016/s0093-7754(01)90113-7. Semin Oncol. 2001. PMID: 11402430 No abstract available.

8

Rationale and clinical trial design for evaluating gemcitabine as neoadjuvant and adjuvant therapy for breast cancer.

Mamounas EP, Geyer CE Jr, Swain SM. Mamounas EP, et al. Among authors: swain sm. Clin Breast Cancer. 2004 Jan;4 Suppl 3:S121-6. doi: 10.3816/cbc.2004.s.006. Clin Breast Cancer. 2004. PMID: 14754470 Review.

9

Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer.

Swain SM, Wilson JW, Mamounas EP, Bryant J, Wickerham DL, Fisher B, Paik S, Wolmark N. Swain SM, et al. J Natl Cancer Inst. 2004 Apr 7;96(7):516-23. doi: 10.1093/jnci/djh097. J Natl Cancer Inst. 2004. PMID: 15069113

10

Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in metastatic and locally advanced breast cancer.

Low JA, Wedam SB, Lee JJ, Berman AW, Brufsky A, Yang SX, Poruchynsky MS, Steinberg SM, Mannan N, Fojo T, Swain SM. Low JA, et al. Among authors: swain sm. J Clin Oncol. 2005 Apr 20;23(12):2726-34. doi: 10.1200/JCO.2005.10.024. J Clin Oncol. 2005. PMID: 15837987 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

322 results

Search Page